Table 1.
Tissue Type | Number of Upregulated Samples/Number of Samples (%) 1 |
Fold Induction Compared to Normal Prostate Tissue 2 |
---|---|---|
Adenocarcinoma of prostate (stage I) | 9/26 (34.6%) | 2 to 10 |
Adenocarcinoma of prostate (stage II) | 13/29 (44.8%) | 5 to 50 |
Adenocarcinoma of prostate (stage III) | 7/16 (43.75%) | 20 to 2000 |
BPH | 0/10 (0%) | 0 |
Carcinoma of bladder, transition tissue | 0/2 (0%) | 0 |
1 DCUN1D1 is upregulated in 29/69 (42%) of clinical samples analysed. 2 The results are shown as fold of induction compared with the values obtained in normal prostate.